Acyclovir Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with acyclovir
C
- Canasa (mesalamine)
- Canasa Pac (mesalamine)
- Capastat (capreomycin)
- Capastat Sulfate (capreomycin)
- capreomycin
- Cardiografin (diatrizoate)
- ceftazidime
- CellCept (mycophenolate mofetil)
- Ceptaz (ceftazidime)
- Cerebyx (fosphenytoin)
- Choledyl (oxtriphylline)
- Choledyl SA (oxtriphylline)
- Cholografin Meglumine (iodipamide)
- cidofovir
- Cimduo (lamivudine / tenofovir)
- cladribine
- Cladribine Novaplus (cladribine)
- clofarabine
- Clolar (clofarabine)
- cobicistat / darunavir / emtricitabine / tenofovir alafenamide
- cobicistat / elvitegravir / emtricitabine / tenofovir
- cobicistat / elvitegravir / emtricitabine / tenofovir alafenamide
- Colazal (balsalazide)
- colchicine / probenecid
- colistimethate
- Coly Mycin M (colistimethate)
- Combivir (lamivudine / zidovudine)
- Complera (emtricitabine / rilpivirine / tenofovir)
- Conray (iothalamate)
- Conray-30 (iothalamate)
- Conray-400 (iothalamate)
- Conray-43 (iothalamate)
- Constant-T (theophylline)
- cyclosporine
- Cysto-Conray (iothalamate)
- Cysto-Conray II (iothalamate)
- Cystografin (diatrizoate)
- Cystografin-Dilute (diatrizoate)
More about acyclovir
- acyclovir consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (187)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: purine nucleosides
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.